Bayzed Health Group Inc (HKG:2609)

Bayzed Health Group Statistics

Total Valuation

HKG:2609 has a market cap or net worth of HKD 8.62 billion. The enterprise value is 8.96 billion.

Market Cap	8.62B
Enterprise Value	8.96B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

HKG:2609 has 1.32 billion shares outstanding.

Current Share Class	1.32B
Shares Outstanding	1.32B
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	51.75%
Owned by Institutions (%)	19.57%
Float	538.76M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.82
PB Ratio	6.93
P/TBV Ratio	42.69
P/FCF Ratio	65.00
P/OCF Ratio	48.08
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 71.85, with an EV/FCF ratio of 67.54.

EV / Earnings	-625.68
EV / Sales	7.08
EV / EBITDA	71.85
EV / EBIT	261.91
EV / FCF	67.54

Financial Position

The company has a current ratio of 0.97, with a Debt / Equity ratio of 0.44.

Current Ratio	0.97
Quick Ratio	0.73
Debt / Equity	0.44
Debt / EBITDA	4.41
Debt / FCF	4.15
Interest Coverage	1.50

Financial Efficiency

Return on equity (ROE) is -0.30% and return on invested capital (ROIC) is 1.18%.

Return on Equity (ROE)	-0.30%
Return on Assets (ROA)	0.91%
Return on Invested Capital (ROIC)	1.18%
Return on Capital Employed (ROCE)	2.26%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.54
Inventory Turnover	13.01

Taxes

In the past 12 months, HKG:2609 has paid 17.95 million in taxes.

Income Tax	17.95M
Effective Tax Rate	126.72%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	66.40
Average Volume (20 Days)	3,015,873

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2609 had revenue of HKD 1.27 billion and -14.32 million in losses. Loss per share was -0.01.

Revenue	1.27B
Gross Profit	221.56M
Operating Income	34.21M
Pretax Income	14.17M
Net Income	-14.32M
EBITDA	96.67M
EBIT	34.21M
Loss Per Share	-0.01

Balance Sheet

The company has 320.43 million in cash and 550.45 million in debt, giving a net cash position of -230.03 million or -0.17 per share.

Cash & Cash Equivalents	320.43M
Total Debt	550.45M
Net Cash	-230.03M
Net Cash Per Share	-0.17
Equity (Book Value)	1.25B
Book Value Per Share	0.96
Working Capital	-25.31M

Cash Flow

In the last 12 months, operating cash flow was 179.36 million and capital expenditures -46.69 million, giving a free cash flow of 132.67 million.

Operating Cash Flow	179.36M
Capital Expenditures	-46.69M
Free Cash Flow	132.67M
FCF Per Share	0.10

Margins

Gross margin is 17.51%, with operating and profit margins of 2.70% and -1.13%.

Gross Margin	17.51%
Operating Margin	2.70%
Pretax Margin	1.12%
Profit Margin	-1.13%
EBITDA Margin	7.64%
EBIT Margin	2.70%
FCF Margin	10.49%

Dividends & Yields

HKG:2609 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-0.17%
FCF Yield	1.54%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:2609 has an Altman Z-Score of 0.38 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.38
Piotroski F-Score	6